Table 3.

Multivariable analysis for serologic response

Factor	Odds ratio (95% CI; P-value)
Initial vaccination cohort
Treatment, naïve and B-cell-directed
No B-cell-directed therapy, treatment naïve	1
No B-cell-directed therapy, not treatment naïve	0.34 (0.15-0.78; P = .01)
B-cell-directed therapy	0.19 (0.09-0.41; P < .0001)
Gender
Male	1
Female	1.54 (0.82-2.90; P = .18)
Age (as continuous variable)	0.96 (0.93-0.99; P = .02)
Booster vaccination cohort
Treatment-naïve status
No	1
Yes	1.86 (0.78-4.43; P = .16)
Gender
Male	1
Female	1.48 (0.63-3.49; P = .37)
Age (as continuous variable)	0.97 (0.93-1.02; P = .20)